Cargando…

Risk of therapy-related myelodysplastic syndrome/acute myeloid leukemia after childhood cancer: a population-based study

Detalles Bibliográficos
Autores principales:	Advani, Pragati G., Schonfeld, Sara J., Curtis, Rochelle E., Dores, Graça M., Linet, Martha S., Sigel, Byron S., Lam, Clara J. K., Tucker, Margaret A., Chanock, Stephen J., Morton, Lindsay M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6884663/ https://www.ncbi.nlm.nih.gov/pubmed/31341236 http://dx.doi.org/10.1038/s41375-019-0520-y

Ejemplares similares

Trends in risk for therapy-related myelodysplastic syndrome/acute myeloid leukemia after initial chemo/immunotherapy for common and rare lymphoid neoplasms, 2000–2018
por: Morton, Lindsay M., et al.
Publicado: (2023)

Letter to the Editor: Risk factors for second acute myeloid leukemia/myelodysplastic syndrome among survivors of non-Hodgkin lymphoma
por: Lam, Clara J. K., et al.
Publicado: (2015)

Immune-Related Adverse Events After Immune Checkpoint Inhibitors for Melanoma Among Older Adults
por: Schonfeld, Sara J., et al.
Publicado: (2022)

Bone and Soft‐Tissue Sarcoma Risk in Long‐Term Survivors of Hereditary Retinoblastoma Treated With Radiation
por: Kleinerman, Ruth A., et al.
Publicado: (2019)

Epigenetic Treatment of Myelodysplastic Syndromes and Acute Myeloid Leukemias
por: Leone, Giuseppe, et al.
Publicado: (2008)

Immune Therapies for Myelodysplastic Syndromes and Acute Myeloid Leukemia
por: Kapoor, Sargam, et al.
Publicado: (2021)

TP53 Alterations in Myelodysplastic Syndromes and Acute Myeloid Leukemia
por: Rahmé, Ramy, et al.
Publicado: (2023)

Adenoid cystic carcinoma of the breast in the United States (1977 to 2006): a population-based cohort study
por: Ghabach, Bassam, et al.
Publicado: (2010)

Long-term risk of subsequent cancer incidence among hereditary and nonhereditary retinoblastoma survivors
por: Schonfeld, Sara J., et al.
Publicado: (2021)

Measurable Residual Disease-Guided Treatment to Prevent Relapse in Acute Myeloid Leukemia and Myelodysplastic Syndrome
por: Pan, Jonathan, et al.
Publicado: (2020)

Navigating the contested borders between myelodysplastic syndrome and acute myeloid leukemia
por: Ambinder, Alexander J., et al.
Publicado: (2022)

Descriptive epidemiology of childhood leukaemia.
por: Linet, M. S., et al.
Publicado: (1991)

Epigenetic modifications of splicing factor genes in myelodysplastic syndromes and acute myeloid leukemia
por: Wong, Justin J-L, et al.
Publicado: (2014)

Myeloid sarcoma of the Gingiva with myelodysplastic syndrome: A Case Report
por: Jin, Seong-Ho, et al.
Publicado: (2016)

Myelodysplastic Syndrome/Acute Myeloid Leukemia Arising in Idiopathic Erythrocytosis
por: Langabeer, Stephen E., et al.
Publicado: (2018)

Isocitrate Dehydrogenase Mutations in Myelodysplastic Syndromes and in Acute Myeloid Leukemias
por: Testa, Ugo, et al.
Publicado: (2020)

Patient-Physician Communication in Acute Myeloid Leukemia and Myelodysplastic Syndrome
por: Morelli, Emanuela, et al.
Publicado: (2021)

Targeting stem cells in myelodysplastic syndromes and acute myeloid leukemia
por: Woll, Petter S., et al.
Publicado: (2022)

Immune Checkpoint Inhibition in Acute Myeloid Leukemia and Myelodysplastic Syndromes
por: Abaza, Yasmin, et al.
Publicado: (2022)

The Genetic Landscape of Myelodysplastic Neoplasm Progression to Acute Myeloid Leukemia
por: Bănescu, Claudia, et al.
Publicado: (2023)

Secondary myelodysplastic syndrome/acute myeloid leukaemia following mitoxantrone-based therapy for breast carcinoma
por: Saso, R, et al.
Publicado: (2000)

Familial Myelodysplastic/Acute Leukemia Syndromes—Myeloid Neoplasms with Germline Predisposition
por: Baptista, Renata Lyrio Rafael, et al.
Publicado: (2017)

Systematic review of azacitidine regimens in myelodysplastic syndrome and acute myeloid leukemia
por: Shapiro, Roman M., et al.
Publicado: (2018)

Myelodysplastic Syndrome Progression to Acute Myeloid Leukemia at the Stem Cell Level
por: Chen, Jiahao, et al.
Publicado: (2018)

Acute Myeloid Leukemia with Basophilic Differentiation Transformed from Myelodysplastic Syndrome
por: Tanaka, Yasuhiro, et al.
Publicado: (2017)

Acadesine Circumvents Azacitidine Resistance in Myelodysplastic Syndrome and Acute Myeloid Leukemia
por: Cluzeau, Thomas, et al.
Publicado: (2019)

p300 suppresses the transition of myelodysplastic syndromes to acute myeloid leukemia
por: Man, Na, et al.
Publicado: (2021)

Comparison of acute myeloid leukemia and myelodysplastic syndromes with TP53 aberrations
por: Dutta, Sayantanee, et al.
Publicado: (2022)

Editorial: Uncovering the relationship between myelodysplastic syndromes and acute myeloid leukemia
por: Yassin, Mohamed A., et al.
Publicado: (2023)

Inhibitors of poly ADP-ribose polymerase (PARP) induce apoptosis of myeloid leukemic cells: potential for therapy of myeloid leukemia and myelodysplastic syndromes
por: Gaymes, Terry J, et al.
Publicado: (2021)

Heritable GATA2 Mutations Associated with Familial Myelodysplastic Syndrome and Acute Myeloid Leukemia
por: Hahn, Christopher N., et al.
Publicado: (2011)

Acute myeloid leukemia cells and MSC-derived exosomes inhibiting transformation in myelodysplastic syndrome
por: Liu, Xiaoli, et al.
Publicado: (2023)

The Role of Inhibition of Apoptosis in Acute Leukemias and Myelodysplastic Syndrome
por: McBride, Amanda, et al.
Publicado: (2019)

The role of the atypical chemokine receptor CCRL2 in myelodysplastic syndrome and secondary acute myeloid leukemia
por: Karantanos, Theodoros, et al.
Publicado: (2022)

Effect of invasive aspergillosis on risk for different causes of death in older patients with acute myeloid leukaemia or high-risk myelodysplastic syndrome
por: van Grootveld, Rebecca, et al.
Publicado: (2023)

CCRL2 affects the sensitivity of myelodysplastic syndrome and secondary acute myeloid leukemia cells to azacitidine
por: Karantanos, Theodoros, et al.
Publicado: (2022)

Atypical chronic myeloid leukaemia – a rare subtype of myelodysplastic/myeloproliferative neoplasm
por: Drozd-Sokołowska, Joanna E., et al.
Publicado: (2018)

Circular RNAs in Hematopoiesis with a Focus on Acute Myeloid Leukemia and Myelodysplastic Syndrome
por: Dostalova Merkerova, Michaela, et al.
Publicado: (2020)

Myeloid-derived suppressor cell cytokine secretion as prognostic factor in myelodysplastic syndromes
por: Han, Dong, et al.
Publicado: (2020)

Hypomethylating Agents and Immunotherapy: Therapeutic Synergism in Acute Myeloid Leukemia and Myelodysplastic Syndromes
por: Wong, Kah Keng, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_0epum8etdo8slc1n46vmerb1ae